# Goodcare Pharma Pvt. Ltd. · 99-39 · INDIA — FDA import alert red lists: firms subject to detention without physical examination

For Goodcare Pharma Pvt. Ltd. · 99-39 · INDIA, import alert is 99-39; import alert name is Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded; country is INDIA; product is Kaishore Guggulu (Goodcare Brand) | Arthplus (Leaf Care Brand) | Moringa (Leaf Care Brand) | Kaishore Guggulu (Goodcare Brand) | Arthplus (Leaf Care Brand); product code is 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. | 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. | 54 K - - 10 Moringa Oleifera (Herbal and Botanical (not Teas II) contd | 66 V - - 99 Miscellaneous Patent Medicines, Etc. | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 11/08/2023; address is VI/VII Bagi, Bishnupur , South Twenty Four Parganas , West Bengal, INDIA, verified against its source on 2026-09-16.

- **Firm:** Goodcare Pharma Pvt. Ltd. _(verified: appears in the quote below)_
- **Import alert:** 99-39
- **Import alert name:** Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded
- **Country:** INDIA _(verified: appears in the quote below)_
- **Address:** VI/VII Bagi, Bishnupur , South Twenty Four Parganas , West Bengal, INDIA _(verified: appears in the quote below)_
- **Date published:** 11/08/2023 _(verified: appears in the quote below)_
- **Product code:** 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. | 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. | 54 K - - 10 Moringa Oleifera (Herbal and Botanical (not Teas II) contd | 66 V - - 99 Miscellaneous Patent Medicines, Etc. | 66 V - - 99 Miscellaneous Patent Medicines, Etc. _(verified: each item appears in the quote below)_
- **Product:** Kaishore Guggulu (Goodcare Brand) | Arthplus (Leaf Care Brand) | Moringa (Leaf Care Brand) | Kaishore Guggulu (Goodcare Brand) | Arthplus (Leaf Care Brand) _(verified: each item appears in the quote below)_
- **FDA notes:** The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product appears to be misbranded within the meaning of: Section 403(f) of the Act because the label fails to display the standard of identity in lines generally parallel to the base on which the package rests as it is designed to be displayed, in accordance with 21 CFR 101.3(d). Section 403(i)(2) of the Act in that the product labels fail to declare the common or usual names of each ingredient used as required by 21 CFR 101.36 and 21 CFR 101.4., and in that the products are fabricated from two or more ingredients, but the labels fail to list the individual excipients as required by 21 CFR 101.4(a) and (g). Section 403(q)(5)(F) of the Act in that the presentation of the nutrition information on the labeling of the products does not comply with 21 CFR 101.36. Section 403(s)(2)(C) of the Act in that the labels fail to identify the part of the plant (e.g., root, leaves) from which each botanical dietary ingredient in the product is derived, as required by 21 CFR 101.4(h)(1); if the whole or entire plant is used, that information must be listed. Section 403(y) of the Act in that the label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761 of the Act) may receive a report of a serious adverse event with such dietary supplement. | The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product appears to be misbranded within the meaning of: Section 403(f) of the Act because the label fails to display the standard of identity in lines generally parallel to the base on which the package rests as it is designed to be displayed, in accordance with 21 CFR 101.3(d). Section 403(i)(2) of the Act in that the product labels fail to declare the common or usual names of each ingredient used as required by 21 CFR 101.36 and 21 CFR 101.4., and in that the products are fabricated from two or more ingredients, but the labels fail to list the individual excipients as required by 21 CFR 101.4(a) and (g). Section 403(q)(5)(F) of the Act in that the presentation of the nutrition information on the labeling of the products does not comply with 21 CFR 101.36. Section 403(s)(2)(C) of the Act in that the labels fail to identify the part of the plant (e.g., root, leaves) from which each botanical dietary ingredient in the product is derived, as required by 21 CFR 101.4(h)(1); if the whole or entire plant is used, that information must be listed. Section 403(y) of the Act in that the label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761 of the Act) may receive a report of a serious adverse event with such dietary supplement. | The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product appears to be misbranded within the meaning of: Section 403(f) of the Act because the label fails to display the standard of identity in lines generally parallel to the base on which the package rests as it is designed to be displayed, in accordance with 21 CFR 101.3(d). Section 403(i)(2) of the Act in that the product labels fail to declare the common or usual names of each ingredient used as required by 21 CFR 101.36 and 21 CFR 101.4., and in that the products are fabricated from two or more ingredients, but the labels fail to list the individual excipients as required by 21 CFR 101.4(a) and (g). Section 403(q)(5)(F) of the Act in that the presentation of the nutrition information on the labeling of the products does not comply with 21 CFR 101.36. Section 403(s)(2)(C) of the Act in that the labels fail to identify the part of the plant (e.g., root, leaves) from which each botanical dietary ingredient in the product is derived, as required by 21 CFR 101.4(h)(1); if the whole or entire plant is used, that information must be listed. Section 403(y) of the Act in that the label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761 of the Act) may receive a report of a serious adverse event with such dietary supplement. | The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product appears to be misbranded within the meaning of: Section 403(f) of the Act because the label fails to display the standard of identity in lines generally parallel to the base on which the package rests as it is designed to be displayed, in accordance with 21 CFR 101.3(d). Section 403(i)(2) of the Act in that the product labels fail to declare the common or usual names of each ingredient used as required by 21 CFR 101.36 and 21 CFR 101.4., and in that the products are fabricated from two or more ingredients, but the labels fail to list the individual excipients as required by 21 CFR 101.4(a) and (g). Section 403(q)(5)(F) of the Act in that the presentation of the nutrition information on the labeling of the products does not comply with 21 CFR 101.36. Section 403(s)(2)(C) of the Act in that the labels fail to identify the part of the plant (e.g., root, leaves) from which each botanical dietary ingredient in the product is derived, as required by 21 CFR 101.4(h)(1); if the whole or entire plant is used, that information must be listed. Section 403(y) of the Act in that the label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761 of the Act) may receive a report of a serious adverse event with such dietary supplement. | The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product appears to be misbranded within the meaning of: Section 403(f) of the Act because the label fails to display the standard of identity in lines generally parallel to the base on which the package rests as it is designed to be displayed, in accordance with 21 CFR 101.3(d). Section 403(i)(2) of the Act in that the product labels fail to declare the common or usual names of each ingredient used as required by 21 CFR 101.36 and 21 CFR 101.4., and in that the products are fabricated from two or more ingredients, but the labels fail to list the individual excipients as required by 21 CFR 101.4(a) and (g). Section 403(q)(5)(F) of the Act in that the presentation of the nutrition information on the labeling of the products does not comply with 21 CFR 101.36. Section 403(s)(2)(C) of the Act in that the labels fail to identify the part of the plant (e.g., root, leaves) from which each botanical dietary ingredient in the product is derived, as required by 21 CFR 101.4(h)(1); if the whole or entire plant is used, that information must be listed. Section 403(y) of the Act in that the label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761 of the Act) may receive a report of a serious adverse event with such dietary supplement. _(verified: each item appears in the quote below)_

## What the source says

> Goodcare Pharma Pvt. Ltd. Date Published : 11/08/2023 VI/VII Bagi, Bishnupur , South Twenty Four Parganas , West Bengal, INDIA 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. Date Published: 11/08/2023 Desc: Kaishore Guggulu (Goodcare Brand) Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product appears to be misbranded within the meaning of: Section 403(f) of the Act because the label fails to display the standard of identity in lines generally parallel to the base on which the package rests as it is designed to be displayed, in accordance with 21 CFR 101.3(d). Section 403(i)(2) of the Act in that the product labels fail to declare the common or usual names of each ingredient used as required by 21 CFR 101.36 and 21 CFR 101.4., and in that the products are fabricated from two or more ingredients, but the labels fail to list the individual excipients as required by 21 CFR 101.4(a) and (g). Section 403(q)(5)(F) of the Act in that the presentation of the nutrition information on the labeling of the products does not comply with 21 CFR 101.36. Section 403(s)(2)(C) of the Act in that the labels fail to identify the part of the plant (e.g., root, leaves) from which each botanical dietary ingredient in the product is derived, as required by 21 CFR 101.4(h)(1); if the whole or entire plant is used, that information must be listed. Section 403(y) of the Act in that the label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761 of the Act) may receive a report of a serious adverse event with such dietary supplement. 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. Date Published: 11/08/2023 Desc: Arthplus (Leaf Care Brand) Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product appears to be misbranded within the meaning of: Section 403(f) of the Act because the label fails to display the standard of identity in lines generally parallel to the base on which the package rests as it is designed to be displayed, in accordance with 21 CFR 101.3(d). Section 403(i)(2) of the Act in that the product labels fail to declare the common or usual names of each ingredient used as required by 21 CFR 101.36 and 21 CFR 101.4., and in that the products are fabricated from two or more ingredients, but the labels fail to list the individual excipients as required by 21 CFR 101.4(a) and (g). Section 403(q)(5)(F) of the Act in that the presentation of the nutrition information on the labeling of the products does not comply with 21 CFR 101.36. Section 403(s)(2)(C) of the Act in that the labels fail to identify the part of the plant (e.g., root, leaves) from which each botanical dietary ingredient in the product is derived, as required by 21 CFR 101.4(h)(1); if the whole or entire plant is used, that information must be listed. Section 403(y) of the Act in that the label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761 of the Act) may receive a report of a serious adverse event with such dietary supplement. 54 K - - 10 Moringa Oleifera (Herbal and Botanical (not Teas II) contd Date Published: 11/08/2023 Desc: Moringa (Leaf Care Brand) Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product appears to be misbranded within the meaning of: Section 403(f) of the Act because the label fails to display the standard of identity in lines generally parallel to the base on which the package rests as it is designed to be displayed, in accordance with 21 CFR 101.3(d). Section 403(i)(2) of the Act in that the product labels fail to declare the common or usual names of each ingredient used as required by 21 CFR 101.36 and 21 CFR 101.4., and in that the products are fabricated from two or more ingredients, but the labels fail to list the individual excipients as required by 21 CFR 101.4(a) and (g). Section 403(q)(5)(F) of the Act in that the presentation of the nutrition information on the labeling of the products does not comply with 21 CFR 101.36. Section 403(s)(2)(C) of the Act in that the labels fail to identify the part of the plant (e.g., root, leaves) from which each botanical dietary ingredient in the product is derived, as required by 21 CFR 101.4(h)(1); if the whole or entire plant is used, that information must be listed. Section 403(y) of the Act in that the label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761 of the Act) may receive a report of a serious adverse event with such dietary supplement. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 11/08/2023 Desc: Kaishore Guggulu (Goodcare Brand) Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product appears to be misbranded within the meaning of: Section 403(f) of the Act because the label fails to display the standard of identity in lines generally parallel to the base on which the package rests as it is designed to be displayed, in accordance with 21 CFR 101.3(d). Section 403(i)(2) of the Act in that the product labels fail to declare the common or usual names of each ingredient used as required by 21 CFR 101.36 and 21 CFR 101.4., and in that the products are fabricated from two or more ingredients, but the labels fail to list the individual excipients as required by 21 CFR 101.4(a) and (g). Section 403(q)(5)(F) of the Act in that the presentation of the nutrition information on the labeling of the products does not comply with 21 CFR 101.36. Section 403(s)(2)(C) of the Act in that the labels fail to identify the part of the plant (e.g., root, leaves) from which each botanical dietary ingredient in the product is derived, as required by 21 CFR 101.4(h)(1); if the whole or entire plant is used, that information must be listed. Section 403(y) of the Act in that the label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761 of the Act) may receive a report of a serious adverse event with such dietary supplement. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 11/08/2023 Desc: Arthplus (Leaf Care Brand) Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product appears to be misbranded within the meaning of: Section 403(f) of the Act because the label fails to display the standard of identity in lines generally parallel to the base on which the package rests as it is designed to be displayed, in accordance with 21 CFR 101.3(d). Section 403(i)(2) of the Act in that the product labels fail to declare the common or usual names of each ingredient used as required by 21 CFR 101.36 and 21 CFR 101.4., and in that the products are fabricated from two or more ingredients, but the labels fail to list the individual excipients as required by 21 CFR 101.4(a) and (g). Section 403(q)(5)(F) of the Act in that the presentation of the nutrition information on the labeling of the products does not comply with 21 CFR 101.36. Section 403(s)(2)(C) of the Act in that the labels fail to identify the part of the plant (e.g., root, leaves) from which each botanical dietary ingredient in the product is derived, as required by 21 CFR 101.4(h)(1); if the whole or entire plant is used, that information must be listed. Section 403(y) of the Act in that the label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761 of the Act) may receive a report of a serious adverse event with such dietary supplement.

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_1144.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).